We are delighted to announce that 11 of the 14 Contractors who completed Phase 1 have been selected to enter Phase 2 and were awarded contracts on the 15th of November 2022 for development of prototypes based on their Solution Designs.

Further details including the project abstracts can be found under Phase 2 – Prototype Development

The successful Contractors are:

Lot 1: (Consortium Lead)

Integrated DNA Technologies, BV  

QIAGEN GmbH                                    

Twist Bioscience Corporation          

Lot 3: (Consortium Lead)

BC Platforms AG                                 

Congenica Ltd                                     

FUNDACIO CENTRE DE REGULACIO GENOMICA         

Platomics GmbH                                 

Lot 4: (Consortium Lead)

BC Platforms AG                                

Congenica Ltd                                  

fragmentiX Storage Solutions GmbH             

FUNDACIO CENTRE DE REGULACIO GENOMICA